Just checking Amgen and their strategy and seems like they are investigating combo therapies to get the most out of Krypolis (carfilzomib). Plus investigations on ALL, MRD and Multiple Myeloma. Guess (carfilzomib) cardio protective combo with Zantrene is not a mere fluke along with other indications.
Oldest trick in the book, Find a problem that already exists and present the solution!
Source: Amgen Announces New Data Being Presented At ASH 2021| Amgen
- Forums
- General
- General Comments / Chat
Just checking Amgen and their strategy and seems like they are...
-
- There are more pages in this discussion • 6,575 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.86 |
Change
-0.015(0.80%) |
Mkt cap ! $316.8M |
Open | High | Low | Value | Volume |
$1.88 | $1.88 | $1.79 | $163.0K | 89.00K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 34299 | $1.84 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.86 | 3635 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 34299 | 1.840 |
1 | 3000 | 1.810 |
1 | 1106 | 1.800 |
1 | 1231 | 1.790 |
1 | 11000 | 1.780 |
Price($) | Vol. | No. |
---|---|---|
1.860 | 3635 | 1 |
1.875 | 198 | 1 |
1.895 | 3000 | 1 |
1.900 | 33 | 1 |
1.940 | 5148 | 2 |
Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |